Form 4 Tracker
RHYTHM PHARMACEUTICALS, INC.
RYTM

43 insider filings · Latest: Sep 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 6, 2024Nov 6 10:07 PMPAMELA CRAMER
Proposed Sale
4,687$56.25$263.6K—

View →

Sep 17, 2024Sep 17 8:42 PMJENNIFER GOOD
Proposed Sale
31,751$49.52$1.6M—

View →

Sep 10, 2024Sep 10 8:22 PMLYNN TETRAULT393 COMMONWEALTH AVE
Proposed Sale
17,501$50.66$886.6K—

View →

Sep 9, 2024Sep 9 8:31 PMJENNIFER GOOD
Proposed Sale
16,749$49.25$824.9K—

View →

Aug 26, 2024Aug 26 8:27 PMJENNIFER GOOD
Proposed Sale
35,000$46.12$1.6M—

View →

Aug 26, 2024Aug 26 8:27 PMLYNN TETRAULT393 COMMONWEALTH AVE
Proposed Sale
7,499$46.12$345.9K—

View →

Aug 26, 2024Aug 26 8:26 PMPAMELA CRAMER
Proposed Sale
7,299$46.12$336.6K—

View →

Nov 11, 2024—JENNIFER KAYDEN LEE
Proposed Sale
66,861$67.33$4.5M—

View →

Nov 11, 2024—JOSEPH J SHULMAN
Proposed Sale
13,281$67.33$894.2K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 1, 2026Feb 3 9:32 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
3,613—5,418(D)

View →

Feb 1, 2026Feb 3 9:31 PMAlastair GarfieldChief Scientific Officer
Option Exercise
6,663—19,987(D)

View →

Feb 1, 2026Feb 3 9:30 PMPamela J. CramerChief Human Resources Officer
Option Exercise
13,293—15,000(D)

View →

← Previous

Page 3 of 3